ES8304096A1 - "procedimiento para la preparacion de nuevas piriimidinonas". - Google Patents

"procedimiento para la preparacion de nuevas piriimidinonas".

Info

Publication number
ES8304096A1
ES8304096A1 ES82511835A ES511835A ES8304096A1 ES 8304096 A1 ES8304096 A1 ES 8304096A1 ES 82511835 A ES82511835 A ES 82511835A ES 511835 A ES511835 A ES 511835A ES 8304096 A1 ES8304096 A1 ES 8304096A1
Authority
ES
Spain
Prior art keywords
formula
pyrimidones
preparation
reaction
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES82511835A
Other languages
English (en)
Other versions
ES511835A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803046871 external-priority patent/DE3046871A1/de
Priority claimed from DE19813115447 external-priority patent/DE3115447A1/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES8304096A1 publication Critical patent/ES8304096A1/es
Publication of ES511835A0 publication Critical patent/ES511835A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE PIRIMIDINONAS Y DE SUS SALES, DE FORMULA (I), EN LA QUE D ES ALCOHILENO O HIDROXIALCOHILENO; R Y R SON HIDROGENO O ALCOHILO; R ES HIDROXI O ALCOXI; Y A, B Y R PUEDEN SER VARIOS RADICALES; COMPUESTOS QUE TIENEN APLICACIONES FARMACOLOGICAS POR SU EFECTO HIPOTENSOR, ANTIARRITMICO Y BLOQUEANTE DE ~J-RECEPTORES. CONSISTE EN LA REACCION DE ALCOHILACION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA Z-Y, EN LAS QUE Z ES UN GRUPO SUSTITUIBLE NUCLEOFILICAMENTE; Y ES R , R O R ; Y TODOS LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE ORGANICO, A UNA TEMPERATURA ENTRE 0 C Y 180 C.
ES82511835A 1980-12-12 1982-04-30 "procedimiento para la preparacion de nuevas piriimidinonas". Granted ES511835A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803046871 DE3046871A1 (de) 1980-12-12 1980-12-12 Neue chinazolinone, ihre herstellung und ihre verwendung als arzneimittel
DE19813115447 DE3115447A1 (de) 1981-04-16 1981-04-16 Neue pyrimidinone, ihre herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES8304096A1 true ES8304096A1 (es) 1983-02-16
ES511835A0 ES511835A0 (es) 1983-02-16

Family

ID=25789685

Family Applications (2)

Application Number Title Priority Date Filing Date
ES507761A Granted ES507761A0 (es) 1980-12-12 1981-12-07 Procedimiento para la preparacion de nuevas pirimidinonas .
ES82511835A Granted ES511835A0 (es) 1980-12-12 1982-04-30 "procedimiento para la preparacion de nuevas piriimidinonas".

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES507761A Granted ES507761A0 (es) 1980-12-12 1981-12-07 Procedimiento para la preparacion de nuevas pirimidinonas .

Country Status (22)

Country Link
US (1) US4379788A (es)
EP (1) EP0054132B1 (es)
AR (1) AR227567A1 (es)
AU (1) AU543568B2 (es)
CA (1) CA1217767A (es)
CS (1) CS227024B2 (es)
DD (1) DD208151A5 (es)
DE (1) DE3166627D1 (es)
DK (1) DK525481A (es)
ES (2) ES507761A0 (es)
FI (1) FI813971L (es)
GB (1) GB2090249B (es)
GR (1) GR76952B (es)
HU (1) HU187384B (es)
IL (1) IL64504A (es)
MY (1) MY8700562A (es)
NO (1) NO814239L (es)
NZ (1) NZ199254A (es)
PH (1) PH18930A (es)
PL (1) PL135330B1 (es)
PT (1) PT74116B (es)
SU (1) SU1056900A3 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460589A (en) * 1980-10-03 1984-07-17 The Upjohn Company Process for treating hypertension
US4379778A (en) * 1980-10-10 1983-04-12 Air Products And Chemicals, Inc. Hydrogen peroxide synthesis
DE3428476A1 (de) * 1984-08-02 1986-02-13 Basf Ag, 6700 Ludwigshafen 4h-pyrido(2,3-d)(1,3)oxazin-4-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3631294A1 (de) * 1986-09-13 1988-03-24 Thomae Gmbh Dr K Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung
US5037980A (en) * 1988-04-18 1991-08-06 American Cyanamid Company Phenyl imidazo[1,2-a]pyrimidines
GB8928346D0 (en) * 1989-12-15 1990-02-21 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
HU227841B1 (en) 1997-11-12 2012-05-02 Bayer Pharma AG 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
RU2207337C2 (ru) * 1998-11-18 2003-06-27 Изаксон Елена Александровна 6-(3-ацетилфенил)аминоурацил
US20040102324A1 (en) 2002-02-28 2004-05-27 Annis Gary David Heterocyclic diamide invertebrate pest control agents
US6642244B2 (en) 2001-03-16 2003-11-04 Bristol-Myers Squibb Co. Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
US7893071B2 (en) * 2001-04-23 2011-02-22 University Of Virginia Patent Foundation Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic
AU2002314044B2 (en) * 2001-05-09 2006-09-21 Bayer Healthcare Ag Novel use of 2-phenyl-substituted imidazotriazinones
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
CA2549641A1 (en) * 2003-12-19 2005-07-21 Merck & Co., Inc. Mitotic kinesin inhibitors
SE0401345D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds: Pyridine as scaffold
SE0401342D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds
JPWO2005115993A1 (ja) * 2004-05-31 2008-03-27 萬有製薬株式会社 キナゾリン誘導体
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
CA2623657A1 (en) * 2005-09-29 2007-04-12 Bayer Healthcare Ag Pde inhibitors and combinations thereof for the treatment of urological disorders
CA2663436A1 (en) * 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
JP2010532319A (ja) * 2007-06-13 2010-10-07 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 聴覚障害の処置用のｐｄｅ阻害剤
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
WO2009139834A1 (en) * 2008-05-13 2009-11-19 Poniard Pharmaceuticals, Inc. Bioactive compounds for treatment of cancer and neurodegenerative diseases
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
MX362855B (es) 2012-09-26 2019-02-20 Merck Patent Gmbh Derivados de quinazolinona como inhidores poli (adp-ribosa) polimerasa (parp).

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265697A (en) * 1964-09-04 1966-08-09 Shulton Inc 2-p-dialkylaminoalkoxyphenyl-2, 3-dihydro-4 (1h)-quinazolinones and their derivatives
DE1939109A1 (de) * 1968-08-31 1970-03-05 Troponwerke Dinklage & Co 2-Methyl-3-[2-(2-diaethylaminoaethoxy)-phenyl]-chinazolinon-(4) und Verfahren zu seiner Herstellung
US3862191A (en) * 1972-09-27 1975-01-21 Pfizer Pyrido{8 2,3-d{9 pyrimidin-4(3H)-one

Also Published As

Publication number Publication date
PT74116A (de) 1982-01-01
ES8207156A1 (es) 1982-09-01
IL64504A0 (en) 1982-03-31
GB2090249B (en) 1984-08-22
MY8700562A (en) 1987-12-31
AU7847381A (en) 1982-06-17
NO814239L (no) 1982-06-14
IL64504A (en) 1985-02-28
EP0054132A1 (de) 1982-06-23
US4379788A (en) 1983-04-12
FI813971A7 (fi) 1982-06-13
FI813971L (fi) 1982-06-13
ES507761A0 (es) 1982-09-01
DE3166627D1 (en) 1984-11-15
HU187384B (en) 1985-12-28
SU1056900A3 (ru) 1983-11-23
CA1217767A (en) 1987-02-10
DK525481A (da) 1982-06-13
PT74116B (de) 1983-12-19
PL135330B1 (en) 1985-10-31
EP0054132B1 (de) 1984-10-10
DD208151A5 (de) 1984-03-28
PL234175A1 (es) 1982-08-16
GR76952B (es) 1984-09-04
PH18930A (en) 1985-11-11
NZ199254A (en) 1985-02-28
CS227024B2 (en) 1984-04-16
AU543568B2 (en) 1985-04-26
ES511835A0 (es) 1983-02-16
GB2090249A (en) 1982-07-07
AR227567A1 (es) 1982-11-15

Similar Documents

Publication Publication Date Title
ES8400415A1 (es) "un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina".
ES8400444A1 (es) Procedimiento para la preparacion de nuevos derivados de carbapenem.
ES8306156A1 (es) Un procedimiento para la produccion de nuevas cefalosporinas.
ES8304095A1 (es) Un procedimiento para la preparacion de derivados de quinazolina.
ES8404184A1 (es) Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
ES8303382A1 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol.
ES8605506A1 (es) Procedimiento para preparar derivados de piperidina
ES8305681A1 (es) Procedimiento para la obtencion de fenileteres sustituidos.
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8604215A1 (es) Un procedimiento para la preparacion de derivados enol-eteres de oxicanis.
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES8403453A1 (es) Un procedimiento para preparar amidas del acido 1-metil-5-p-toluoilpirrol-2-acetico.
ES8604847A1 (es) Procedimiento para la preparacion de bencileteres sustitui- dos
ES8707731A1 (es) Un procedimiento para la preparacion de derivados de oxindol
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8608502A1 (es) Procedimiento para la obtencion de benzofuranonas
ES8704468A1 (es) Procedimiento para preparar nuevos 1,2,4-triazolo-carbamatos
ES8606381A1 (es) Un procedimiento para preparar un derivado de uridina.
ES8609246A1 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES8506707A1 (es) Un derivado de acido tiazolilacetico
ES8606321A1 (es) Un procedimiento para preparar un derivado de 2-hidroxi-3- (4-fenilpiperazimil)propoxi-benzofurano
ES8202000A1 (es) Procedimiento para preparar pirimidil-quinazolinas
ES8604163A1 (es) Procedimiento para preparar nuevos bencimidazoles
ES8206478A1 (es) Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina